Outcomes and risk factors of different treatments for neuro-cardiac and post-cardiac surgery cerebrovascular disease
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
This study will look at adults with neuro-cardiac conditions or cerebrovascular problems after heart surgery to see which treatment approaches (simultaneous, staged, or conservative) are linked to better or worse outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Beijing Anzhen Hospital Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT07012668 on ClinicalTrials.gov |
What this trial studies
This is an observational cohort conducted at Beijing Anzhen Hospital enrolling adults with neuro-co-cardiological diseases or cerebrovascular disease after cardiac surgery. Patients receiving different management strategies (simultaneous interventional/surgical, staged interventional/surgical, or conservative care) will be followed and clinical outcomes recorded. The study will collect baseline clinical data, procedural details, and postoperative complications to identify factors associated with adverse events. Statistical comparisons and risk-factor analyses will be used to describe outcome differences between treatment approaches.
Who should consider this trial
Good fit: Adults aged 18 or older who have neuro-co-cardiological diseases or cerebrovascular disease following cardiac surgery and who are expected to survive at least one year without other concurrent serious illnesses are ideal candidates.
Not a fit: Patients with expected survival under one year or who have multiple other serious comorbid conditions are unlikely to benefit from findings intended to guide longer-term treatment decisions.
Why it matters
Potential benefit: If successful, the results could help clinicians choose between simultaneous, staged, or conservative approaches to reduce complications and improve recovery for these patients.
How similar studies have performed: Previous observational and randomized studies comparing simultaneous versus staged approaches in combined cardiac and cerebrovascular disease have shown mixed results and no definitive consensus.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥18 years; 2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases. Exclusion Criteria: 1. The expected survival is less than 1 years; 2. Simultaneously merge other serious diseases;
Where this trial is running
Beijing
- Beijing Anzhen Hospital — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Xiaochuan Huo, M.D.
- Email: huoxiaochuan@126.com
- Phone: +86 13716292262
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.